Congressman Adam Kinzinger today supported House passage of H.R. 6, the 21st Century Cures Act.  H.R. 6 is a nonpartisan bill which will incentivize more research for rare diseases and modernizes our health care system to discover, develop, and deliver cures to Americans seeking relief in the fight against disease. A member of the House Energy and Commerce Committee, Kinzinger is a cosponsor of H.R. 6, which passed by a vote 344-77. 

“The 21st Century Cures Act is a unique, nonpartisan effort to truly improve the lives of the American people,” said Kinzinger. “This critical legislation will get life-saving relief to Illinois families faster and more affordably by upgrading our medical innovation infrastructure.  I applaud Chairman Fred Upton (R-MI) and Congresswoman Diana DeGette (D-CO) for their collaborative effort to advance smart, fiscally responsible solutions and hope the Senate quickly follows in our steps.”

More information about H.R. 6, the 21st Century Cures Act:

• Remove barriers to increased research capabilities
• Incorporate the patient perspective into the drug development and regulatory review process
• Measure success and identifying diseases earlier through personalized medicine
• Modernize clinical trials
• Remove regulatory uncertainty for the development of new medical apps
• Provide new incentives for the development of drugs for rare diseases
• Help the entire biomedical ecosystem coordinate more efficiently to find faster cures
• Invest in 21st Century science and next generation investigators
• Helps keep and create jobs here at home
• Reduces the deficit by over $500 million

In addition to resounding support from leading health care experts across the country from both sides of the aisle, this legislation has the backing of over 700 groups encompassing patient advocacy groups, rare disease groups, cancer centers, technology groups, top universities, biopharmaceutical companies, medical device companies, and others from across the country.

 ###